The above concerns are corroborated by the fact that, even in publicly funded healthcare systems, there are virtually no data on the prevalence of BRCA1/2-related cancer control measures at the population level (except those collected with surveys of professionals) [34,35,36] nor studies covering BRCA1/2 testing activities in their entirety. Here, BRCA1 is linked to cancer.